23 Jun SAHPRA and the Sinopharm Vaccine
23June 2021
SAHPRA has received documentation for the Sinopharm vaccine developed by the China National Pharmaceutical Group in China.
SAHPRA will now commence with evaluating the data in assessing the efficacy of the vaccine.